Hard Decoupling: Foreign Firms Less Optimistic About China But Health Sector Revenues Growing

IP, Cybersecurity Concerns Prominent

 
• By Brian Yang

Latest US trade group business survey shows R&D-based pharma and medical device companies continue to see China as an important growth driver but amid unequal market access, ongoing regulatory concerns, and patchy IP protection improvements.

American Chamber of Commerce report show foreign companies are less optimistic about investing in China but health players continue to grow
AMCHAM CHINA LATEST REPORT SHOWS FOREIGN BUSINESS LESS OPTIMISTIC ABOUT CHINA INVESTMENT BUT HEALTH PLAYERS CONTINUE GROWING • Source: Alamy

More from China

More from Asia